Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma (Q84794919)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

main subject

endometrial carcinoma

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Wen-Chun Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Chao-Hsu Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Su-Cheng Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Daw-Yuan Chang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Li-Yun Chou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

23 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

5777-5788

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

Regulatory T cells: key controllers of immunologic self-tolerance

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Immunoregulatory T cells in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulatory T cells and tumour immunity - observations in mice and men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Positive and negative influences of regulatory T cells on tumour immunity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulation of regulatory T cells: role of dendritic cells and toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulating the immune response to tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Cytokine regulation networks in the cancer microenvironment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Tumor-infiltrating T lymphocytes: friends or foes?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

The significance of Treg cells in defective tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Activated CD4+CD25+ T cells selectively kill B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulatory T cells and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

CD8+ regulatory T cells are responsible for GAD-IgG gene-transferred tolerance induction in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Toll-like receptors and immune regulation: implications for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Reversal of tumor-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulatory T cells, tumour immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Exploiting regulatory T-cell populations for the immunotherapy of cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Regulatory T cells and toll-like receptors in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Toll-like receptor signalling on Tregs: to suppress or not to suppress?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25371

7 January 2021

Identifiers

DOI

10.1002/CNCR.25371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20734397%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference